Skip to content
Trial Eligibility
Menu

CogT pSOPT Intervention Study

NCT06005038

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

(JUSTIFICATION: This is the R33 stage of an NIH funded R21/R33 study. R21 stage (IRB-61727) was focused on intervention development; R33 stage will focus on pilot testing the effect of the intervention. The R21 phase was not considered a NIH defined clinical trial; R33 will be considered a NIH defined clinical trial) The purpose is to develop and test the effect of a "personalized" computer-based cognitive training program. The personalized program tailors the difficulty of the training tasks using a participant's biofeedback (i.e., heart rate) and cognitive performance.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Mild Cognitive Impairment
  • Subjective Cognitive Impairment

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
60 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Stanford University
Last updated on ClinicalTrials.gov
May 17, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • CogT Lab, Stanford University · Palo Alto, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.